The Influence of Type 2 Diabetes and Glucose-Lowering Therapies on Cancer Risk in the Taiwanese

Table 3

Adjusted odds ratios and 95% confidence intervals for all cancers associated with antidiabetic drugs, sex, and age in type 2 diabetic patients treated with metformin, sulfonylurea, or insulin monotherapy.

Covariate	Adjusted odds ratio	95% CI	𝑃 value
Antidiabetic drugs
Sulfonylurea versus metformin	1.784	1.406–2.262	<0.001
Insulin versus metformin	1.583	1.389–1.805	<0.001
Sex (female versus male)	0.777	0.692–0.873	<0.001
Age (every 1-yr increment)	1.037	1.033–1.042	<0.001